Vanguard Group »

Rapt Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.5M 3.1M 3.05
2024-03-31 $22M 2.5M 8.98
2023-12-31 $51M 2.1M 24.85
2023-09-30 $34M 2.0M 16.62
2023-06-30 $36M 1.9M 18.70
2023-03-31 $29M 1.6M 18.35
2022-12-31 $30M 1.5M 19.80
2022-06-30 $23M 1.3M 18.25
2022-03-31 $27M 1.2M 21.99
2021-09-30 $34M 1.1M 31.05
2021-06-30 $29M 914k 31.79
2021-03-31 $17M 751k 22.20
2020-12-31 $15M 733k 19.74
2020-09-30 $19M 585k 32.20
2020-06-30 $13M 457k 29.00
2020-03-31 $6.0M 280k 21.27
2019-12-31 $4.0M 144k 27.61